0 participants
Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantation
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2020-10-28
- Start Date:
- 2021-04-01
- Completion:
- 2023-04-01
Conditions
- Allosensitization
- Heart Transplant Failure and Rejection
Interventions
- DRUG
No Results Yet